Antibiotic dosing calculations appear inaccurate for pediatric MRSA infections

01/9/2014 |

Researchers found that calculations for predicting appropriate dosing levels of vancomycin for adults with multidrug-resistant Staphylococcus aureus infections were inaccurate for computing the minimum effective dosages for adolescents between ages 10 and 18. The findings appear in the Journal of Clinical Pharmacology.

View Full Article in:

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI